PGNY Progyny

Progyny to Ring the Nasdaq Stock Market Opening Bell in Recognition of National Infertility Awareness Week®

Progyny to Ring the Nasdaq Stock Market Opening Bell in Recognition of National Infertility Awareness Week®

Nasdaq Partners with Progyny to Bring Comprehensive and Inclusive Fertility and Family Building Benefits to its US Employees

NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, announced today the company will virtually ring the Nasdaq Stock Market Opening Bell on April 22, 2020 in recognition of National Infertility Awareness Week. Progyny also announced today that it is now providing its fertility benefits solution to Nasdaq’s U.S. employees.

National Infertility Awareness Week brings attention to the far-reaching impact of infertility and the struggle that millions of people endure to build their family. Progyny and its partners share a common goal of removing the stigmas and barriers that stand in the way of building families.

To recognize the millions who struggle with infertility and honor the leading employers who are taking action to support their employees achieve their dreams of building a family, David Schlanger, CEO of Progyny, will participate in the virtual Opening Bell Ceremony on April 22, 2020 from 9:15 A.M. to 9:30 A.M. Eastern Time.

“With the difficult situation that the world-wide community is currently struggling with, this is a time when we all reflect on what we value the most, including the importance of family. That makes this an ideal opportunity to recognize and support those who need help to achieve their dreams of family,” said Schlanger. “We are honored to welcome Nasdaq into the Progyny family where they will join over 135 other leading employers who are providing comprehensive and inclusive fertility benefits to their employees.”

“Here at Nasdaq, we are always evaluating new ways to support the Nasdaq family’s needs for the future,” said Bryan Smith, Chief People Officer at Nasdaq. “Adding Progyny to Nasdaq’s Benefits will allow our U.S. employees access to a premier network of fertility specialists, comprehensive coverage for the latest fertility technologies, and personalized support from a dedicated Patient Care Advocate.”

The Opening Bell Ceremony will be webcasted online. If you’d like to view the ceremony live, visit .

To learn more about Progyny, visit .

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the U.S. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians. 

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been named a CNBC 50 Disruptor for three years in a row, to the INC. 5000, Crain’s Fast 50 for NYC, and Modern Healthcare’s Best Places to Work in Healthcare for two years in a row, and Financial Times’ Fastest Growing Companies in the Americas. For more information, visit .

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang

EN
21/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

Progyny, Inc. Announces Fourth Quarter 2025 Results

Progyny, Inc. Announces Fourth Quarter 2025 Results Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent AuthorizationIssues Financial Guidance for 2026, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, t...

 PRESS RELEASE

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2...

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants ...

 PRESS RELEASE

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morga...

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference Anticipates Fourth Quarter and Full Year Results to Be Slightly Above Previously Provided Financial Guidance NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced that the Company is participating in the 44th Annual JP Morgan Healthcare Conference, where it intends to discuss its updated expectations for the quarter and year ending December 31, 2025. “As the fourth quarter progr...

 PRESS RELEASE

New Men’s Health Research from Progyny Challenges Conventional Beliefs...

New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action 75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to stigma, cost, and other barriers. NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: PGNY), a global leader in family building solutions, today announced exploring experiences and views on fertility. The findings shed light on how men in the U.S. view their role in the fertilit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch